• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[妊娠和非妊娠患者宫颈阴道感染的病因学]

[Etiology of cervicovaginal infection in pregnant and non-pregnant patients].

作者信息

Narcio Reyes M L, Solórzano Santos F, Arredondo García J L, Calderón Jaimes E, Beltrán Zúñiga M

出版信息

Ginecol Obstet Mex. 1989 Feb;57:41-6.

PMID:2486979
Abstract

A prospective study to evaluate the prevalence of specific microorganisms in pregnant and nonpregnant women with cervicovaginitis attended at the Instituto Nacional de Perinatología, was done; Candida sp, Gardnerella vaginalis, Replasma urealitycum, Chlamydia trachomatis, Group B Streptococcus, Trichomonas vaginalis, Neisseria gonorrhoeae were investigated. Two hundred thirty four patients were studied, 105/234 (44.9%) pregnant and 129/234 (55.1%) nonpregnant women, with a mean age of 26.5 years (range 14 to 44 years). One hundred eighty one (77.5%) women had only one sexual partner. The most common microorganisms seen were Candida sp (31.6%), Gardnerella vaginalis (27.7) and Ureaplasma urealyticum (15.8%). Infection by Chlamydia trachomatis was documented in 9.8% of the population. Trichomonas vaginalis was identified in 1.7%, there was not any case of Neisseria gonorrhoeae infection. Candida sp and Ureaplasma urealyticum were founded more frequent in the pregnant women than nonpregnant women, 41.9% vs. 24.8% (p less than 0.01) and 20% vs. 12.4% (p less than 0.05) respectively. Group B Streptococci was isolated as a single agent in 4.8% in pregnant women. There were not found any pathogenic microorganisms in 29.9% of the cases, as a causal agent of symptomatic cervicovaginitis.

摘要

在国立围产医学研究所,开展了一项前瞻性研究,以评估患有宫颈炎的孕妇和非孕妇中特定微生物的流行情况;对念珠菌属、阴道加德纳菌、解脲脲原体、沙眼衣原体、B族链球菌、阴道毛滴虫、淋病奈瑟菌进行了调查。共研究了234名患者,其中105名(44.9%)为孕妇,129名(55.1%)为非孕妇,平均年龄为26.5岁(范围14至44岁)。181名(77.5%)女性只有一个性伴侣。最常见的微生物是念珠菌属(31.6%)、阴道加德纳菌(27.7%)和解脲脲原体(15.8%)。9.8%的人群有沙眼衣原体感染记录。阴道毛滴虫的检出率为1.7%,未发现淋病奈瑟菌感染病例。念珠菌属和解脲脲原体在孕妇中的检出率高于非孕妇,分别为41.9%对24.8%(p<0.01)和20%对12.4%(p<0.05)。B族链球菌在孕妇中的单一分离率为4.8%。29.9%的病例未发现任何作为有症状宫颈炎病因的致病微生物。

相似文献

1
[Etiology of cervicovaginal infection in pregnant and non-pregnant patients].[妊娠和非妊娠患者宫颈阴道感染的病因学]
Ginecol Obstet Mex. 1989 Feb;57:41-6.
2
[Cervicovaginal infection as a risk factor for premature labor].[宫颈阴道感染作为早产的一个危险因素]
Ginecol Obstet Mex. 2002 Apr;70:203-9.
3
Risk scores to detect cervical infections in urban antenatal clinic attenders in Mwanza, Tanzania.用于检测坦桑尼亚姆万扎市城市产前诊所就诊者宫颈感染的风险评分。
Sex Transm Infect. 1998 Jun;74 Suppl 1:S139-46.
4
Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum.宫颈细胞学异常女性宫颈阴道微生物的测定:解脲脲原体的作用
Anticancer Res. 2006 Nov-Dec;26(6C):4843-9.
5
Risk factors for Chlamydia trachomatis infection of the cervix: a prospective study of 2000 patients at a family planning clinic.宫颈沙眼衣原体感染的危险因素:对一家计划生育诊所2000名患者的前瞻性研究。
N Z Med J. 1987 Jul 8;100(827):401-3.
6
[Chlamydia trachomatis in the urogenital tract of pregnant women].[孕妇泌尿生殖道中的沙眼衣原体]
Geburtshilfe Frauenheilkd. 1983 Jun;43(6):366-9. doi: 10.1055/s-2008-1036630.
7
Vaginal infections among pregnant women at Omdurman Maternity Hospital in Khartoum, Sudan.苏丹喀土穆恩图曼妇产医院孕妇的阴道感染情况。
J Infect Dev Ctries. 2014 Apr 15;8(4):490-7. doi: 10.3855/jidc.3197.
8
Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic.南非农村女性中未被识别的性传播感染:一种隐匿的流行病。
Bull World Health Organ. 1999;77(1):22-8.
9
Prevalence of low genital tract infectious agents in young Israeli women.
Isr J Med Sci. 1985 Apr;21(4):346-50.
10
[Sexually transmitted diseases (STDs) in a group of adolescents attending a perinatal care institute].[在一家围产期保健机构就诊的一组青少年中的性传播疾病]
Gac Med Mex. 1993 Jan-Feb;129(1):75-9.